Consumer interest in CBD appears to be riding high in Europe but, to many, the route to market through the regulatory quagmire seems as treacherous—and slow—as ever.
On one level, the frustrations of the European cannabidiol (CBD) supplements sector are no different from those of many other ingredient categories where health claims cannot be communicated to consumers or Novel Food regulation stands in the way of market development.
But industry impatience seems particularly intense given that the very complexity of the hemp plant and its compounds which makes it apparently so difficult to regulate at the level of the Single Market is, arguably, just what gives it so many health-and-wellness benefits.
This free report explores the CBD space providing insights around market opportunities and challenges. Download now to discover more about:
Market higher- and lower-growth
Consumer views
Regulations and considerations
PEA: CBD alternative
Science implications
Market forecasts
With the support of:
Read more about:
Reports
.jpg?width=700&auto=webp&quality=80&disable=upscale)
